Literature DB >> 22005015

Akt acutely activates the cholesterogenic transcription factor SREBP-2.

Winnie Luu1, Laura J Sharpe, Julian Stevenson, Andrew J Brown.   

Abstract

Akt is an essential protein kinase for cell growth, proliferation, and survival. Perturbed Akt regulation is associated with a number of human diseases, such as cancer and diabetes. Recently, evidence has emerged that Akt is involved in the regulation of the sterol-regulatory element binding proteins, which are master transcriptional regulators of lipid metabolism. This offers a means by which synthesis of new membrane can be coordinated with cell growth and proliferation. However, the link between Akt and sterol-regulatory element binding protein-2, the major isoform participating in cholesterol regulation, is relatively unexplored. In the present study, we employed insulin-like growth factor-1 as an inducer of Akt signalling, and showed that it increased sterol-regulatory element binding protein-2 activation acutely (within 1h). This insulin-like growth factor-1-induced sterol-regulatory element binding protein-2 activation was blunted when Akt was inhibited pharmacologically or molecularly with small interfering RNA. Furthermore, we employed a rapalog heterodimerisation system to specifically and rapidly activate Akt, and found that sterol-regulatory element binding protein-2 activation was increased in response to Akt activation. Together, this study provides compelling evidence that Akt contributes to the acute regulation of cholesterol metabolism through activating sterol-regulatory element binding protein-2.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005015     DOI: 10.1016/j.bbamcr.2011.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.

Authors:  Yue Zhao; Tian-Yu Wu; Meng-Fei Zhao; Chao-Jun Li
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

2.  The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally.

Authors:  Winnie Luu; Gene Hart-Smith; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2015-01-31       Impact factor: 5.922

Review 3.  Matched and mismatched metabolic fuels in lymphocyte function.

Authors:  Alfredo Caro-Maldonado; Valerie A Gerriets; Jeffrey C Rathmell
Journal:  Semin Immunol       Date:  2013-01-03       Impact factor: 11.130

4.  Twin enzymes, divergent control: The cholesterogenic enzymes DHCR14 and LBR are differentially regulated transcriptionally and post-translationally.

Authors:  Isabelle M Capell-Hattam; Laura J Sharpe; Lydia Qian; Gene Hart-Smith; Anika V Prabhu; Andrew J Brown
Journal:  J Biol Chem       Date:  2020-01-07       Impact factor: 5.157

Review 5.  SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy.

Authors:  Xiang Cheng; Jianying Li; Deliang Guo
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

6.  TRAMP prostate tumor growth is slowed by walnut diets through altered IGF-1 levels, energy pathways, and cholesterol metabolism.

Authors:  Hyunsook Kim; Wallace Yokoyama; Paul Andrew Davis
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

Review 7.  Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.

Authors:  Xilin Yang; Heung M Lee; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2015-03-24       Impact factor: 43.330

Review 8.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

9.  Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.

Authors:  Winnie Luu; Eser J Zerenturk; Ika Kristiana; Martin P Bucknall; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2013-12-20       Impact factor: 5.922

Review 10.  Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR).

Authors:  Laura J Sharpe; Andrew J Brown
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.